Public case informationLast updated
Embecta Securities Fraud Class Action
Embecta · Insulin pens and pen needles · Ongoing Litigation
About this case
Investors filed a securities fraud class action alleging that Embecta and certain senior executives made misleading statements about the strength of the company's insulin pen and pen-needle product category despite alleged competition and market softness. The matter is pending in the U.S. District Court for the District of New Jersey.
Case overview
- Defendant company
- Embecta
- Product or service
- Insulin pens and pen needles
- Case name
- Apitz-Grossman v. Embecta Corp., et al.
- Court case number
- 26-cv-07217
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead-plaintiff application
Participation information
Lead-plaintiff application
Investors in Embecta common stock were invited to seek appointment as lead plaintiff.
Submit information to Bleichmar Fonti & Auld LLP regarding potential lead-plaintiff rights.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
Sources
- Embecta Securities Fraud Class Action
Barchart.com ·
- Embecta Securities Fraud Class Action
Barchart.com ·